Skip to main content

Fungal peritonitis in the Standardizing Care to Improve Outcomes in Pediatric End Stage Renal Disease (SCOPE) Collaborative

Pediatric Nephrology volume 33, pages 873–880 (2018)Cite this article

Abstract

Background

Fungal peritonitis is a serious complication among peritoneal dialysis (PD) patients. The Standardizing Care to Improve Outcomes in Pediatric End Stage Renal Disease (SCOPE) Collaborative is a North American multicenter quality improvement initiative with the primary aim to reduce catheter-related infections in children on chronic dialysis.

Objective

To describe the epidemiology of fungal peritonitis and outcomes of affected patients among pediatric subjects receiving chronic PD and enrolled in SCOPE.

Methods

Data pertaining to PD characteristics, peritonitis episodes and patient outcome were collected between October 2011 and September 2015 from 30 pediatric dialysis centers participating in the SCOPE collaborative. Peritonitis-related data were stratified by etiology, fungal versus bacterial/culture-negative peritonitis. Differences among groups were assessed by Chi-square analysis.

Results

Of 994 patients enrolled in the registry, there were 511 peritonitis episodes of which 41 (8.0%) were fungal. Thirty-six individual patients with 39 unique catheters accounted for the fungal peritonitis episodes. Twenty-three (59%) of the episodes occurred in patients aged < 2 years (p = 0.03). Fungal peritonitis was the initial episode of peritonitis in 48.8% of affected patients, and only 17.1% of these patients had had a previous peritonitis episode within 30 days of the fungal infection. Insertion of the PD catheter at < 2 years of age was associated with an adjusted odds ratio of 2.8 (95% confidence interval 1.24, 6.31) for development of fungal peritonitis compared to older children (p = 0.01). Fungal peritonitis was associated with an increased rate of hospitalization (80.5 vs. 63.4%; p = 0.03), increased length of hospitalization (median of 8 vs. 5 days; p < 0.001) and increased rates of catheter removal (84.6 vs 26.9%; p = 0.001) and technique failure (68.3 vs. 8%; p = 0.001) compared to other causes of peritonitis.

Conclusion

Fungal infections were responsible for 8.0% of peritonitis episodes in the SCOPE collaborative, with the majority of fungal peritonitis episodes occurring in children aged < 2 years. Although no risk factors for infection other than young age were identified, fungal peritonitis was associated with an increased risk of hospitalization, longer hospital stay and an increased frequency of technique failure.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

Fig. 1

References

  1. Sethna CB, Bryant K, Munshi R, Warady BA, Richardson T, Lawlor J, Newland JG, Neu A, Investigators S (2016) Risk factors for and outcomes of catheter-associated peritonitis in children: the SCOPE collaborative. Clin J Am Soc Nephrol 11:1590–1596

    Article  PubMed  PubMed Central  Google Scholar 

  2. Warady BA, Bashir M, Donaldson LA (2000) Fungal peritonitis in children receiving peritoneal dialysis: a report of the NAPRTCS. Kidney Int 58:384–389

    CAS  Article  PubMed  Google Scholar 

  3. Raaijmakers R, Schröder C, Monnens L, Cornelissen E, Warris A (2007) Fungal peritonitis in children on peritoneal dialysis. Pediatr Nephrol 22:288–293

    Article  PubMed  Google Scholar 

  4. Hooman N, Madani A, Sharifian Dorcheh M, Mahdavi A, Derakhshan A, Gheissari A, Esfahani ST, Otukesh H, Mohkam M, Falahzadeh MH, Hosseini Al Hashemi G, Azir A, Merikhi A, Golikhani F, Latif E, Karimi S, Zakavat T, Mohseni P, Ataei N, Nickavar A, Basiratnia M (2007) Fungal peritonitis in Iranian children on continuous ambulatory peritoneal dialysis: a national experience. Iran J Kidney Dis 1:29–33

    PubMed  Google Scholar 

  5. Schaefer F, Feneberg R, Aksu N, Donmez O, Sadikoglu B, Alexander SR, Mir S, Ha IS, Fischbach M, Simkova E, Watson AR, Möller K, von Baum H, Warady BA (2007) Worldwide variation of dialysis-associated peritonitis in children. Kidney Int 72:1374–1379

    CAS  Article  PubMed  Google Scholar 

  6. Matuszkiewicz-Rowinska J (2009) Update on fungal peritonitis and its treatment. Perit Dial Int 29[Suppl 2]:S161–S165

    CAS  PubMed  Google Scholar 

  7. Warady BA, Bakkaloglu S, Newland J, Cantwell M, Verrina E, Neu A, Chadha V, Yap HK, Schaefer F (2012) Consensus guidelines for the prevention and treatment of catheter-related infections and peritonitis in pediatric patients receiving peritoneal dialysis: 2012 update. Perit Dial Int 32[Suppl 2]:S32–S86

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  8. Neu AM, Miller MR, Stuart J, Lawlor J, Richardson T, Martz K, Rosenberg C, Newland J, McAfee N, Begin B, Warady BA, Participants SC (2014) Design of the standardizing care to improve outcomes in pediatric end stage renal disease collaborative. Pediatr Nephrol 29:1477–1484

    Article  PubMed  Google Scholar 

  9. Lee KO, Park SJ, Kim JH, Lee JS, Kim PK, Shin JI (2013) Outcomes of peritonitis in children on peritoneal dialysis: a 25-year experience at severance hospital. Yonsei Med J 54:983–989

    Article  PubMed  PubMed Central  Google Scholar 

  10. Bordador EB, Johnson DW, Henning P, Kennedy SE, McDonald SP, Burke JR, McTaggart SJ, Registry AaNZDaT (2010) Epidemiology and outcomes of peritonitis in children on peritoneal dialysis in Australasia. Pediatr Nephrol 25:1739–1745

    Article  PubMed  Google Scholar 

  11. Zaritsky JJ, Hanevold C, Quigley R, Richardson T, Wong C, Ehrlich J, Lawlor J, Rodean J, Neu A, Warady BA, SCOPE Investigators (2017) Epidemiology of peritonitis following maintenance peritoneal dialysis catheter placement during infancy: a report of the SCOPE collaborative. Pediatr Nephrol. https://doi.org/10.1007/s00467-017-3839-5

  12. Ygberg S, Nilsson A (2012) The developing immune system—from foetus to toddler. Acta Paediatr 101:120–127

    CAS  Article  PubMed  Google Scholar 

  13. Lalan S, Dai H, Warady BA (2017) Hypogammaglobulinemia in infants receiving chronic peritoneal dialysis. Pediatr Nephrol 32:503–509

    Article  PubMed  Google Scholar 

  14. Goldie SJ, Kiernan-Tridle L, Torres C, Gorban-Brennan N, Dunne D, Kliger AS, Finkelstein FO (1996) Fungal peritonitis in a large chronic peritoneal dialysis population: a report of 55 episodes. Am J Kidney Dis 28:86–91

    CAS  Article  PubMed  Google Scholar 

  15. Prasad KN, Prasad N, Gupta A, Sharma RK, Verma AK, Ayyagari A (2004) Fungal peritonitis in patients on continuous ambulatory peritoneal dialysis: a single centre Indian experience. J Inf Secur 48:96–101

    CAS  Google Scholar 

  16. Wang AY, Yu AW, Li PK, Lam PK, Leung CB, Lai KN, Lui SF (2000) Factors predicting outcome of fungal peritonitis in peritoneal dialysis: analysis of a 9-year experience of fungal peritonitis in a single center. Am J Kidney Dis 36:1183–1192

    CAS  Article  PubMed  Google Scholar 

  17. Chou CY, Kao MT, Kuo HL, Liu JS, Liu YL, Huang CC (2006) Gram-negative and polymicrobial peritonitis are associated with subsequent fungal peritonitis in CAPD patients. Perit Dial Int 26:607–608

    PubMed  Google Scholar 

  18. Lo WK, Chan CY, Cheng SW, Poon JF, Chan DT, Cheng IK (1996) A prospective randomized control study of oral nystatin prophylaxis for Candida peritonitis complicating continuous ambulatory peritoneal dialysis. Am J Kidney Dis 28:549–552

    CAS  Article  PubMed  Google Scholar 

  19. Restrepo C, Chacon J, Manjarres G (2010) Fungal peritonitis in peritoneal dialysis patients: successful prophylaxis with fluconazole, as demonstrated by prospective randomized control trial. Perit Dial Int 30:619–625

    Article  PubMed  Google Scholar 

Download references

Author information

Affiliations

  1. Pediatric Nephrology, Seattle Children’s, Seattle, WA, USA

    Raj Munshi

  2. Pediatric Nephrology, Cohen Children’s Medical Center of New York, New Hyde Park, NY, USA

    Christine B. Sethna

  3. Biostatistics, Children’s Hospital Association, Lenexa, KS, USA

    Troy Richardson & Jonathan Rodean

  4. Pediatric Nephrology, Driscoll Children’s Hospital, Corpus Christi, TX, USA

    Samhar Al-Akash

  5. Pediatric Nephrology, University of Louisville, Louisville, KY, USA

    Sushil Gupta

  6. Pediatric Nephrology, Johns Hopkins University School of Medicine, Baltimore, MD, USA

    Alicia M. Neu

  7. Pediatric Nephrology, Children’s Mercy Kansas City, Kansas City, MO, USA

    Bradley A. Warady

Authors
  1. Raj Munshi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Christine B. Sethna
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Troy Richardson
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jonathan Rodean
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Samhar Al-Akash
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Sushil Gupta
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Alicia M. Neu
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Bradley A. Warady
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Raj Munshi.

Ethics declarations

The Institutional Review Board (IRB) at each participating center approved the collaborative protocol and informed consent was obtained where required by the institution’s IRB.

Conflict of interest

The authors declare no conflict of interest.

Appendix

Appendix

Table 5 Participating centers that contributed data to the SCOPE Collaborative
Full size table

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Munshi, R., Sethna, C.B., Richardson, T. et al. Fungal peritonitis in the Standardizing Care to Improve Outcomes in Pediatric End Stage Renal Disease (SCOPE) Collaborative. Pediatr Nephrol 33, 873–880 (2018). https://doi.org/10.1007/s00467-017-3872-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00467-017-3872-4

Keywords

  • Fungal
  • Peritonitis
  • Infection
  • SCOPE
  • Peritoneal dialysis